To validate the potential role of TRPV3 in lung cancer development, we employed TRPV channel blocker RuR and siRNA to inhibit or knockdown TRPV3 expression in A549 and H1299 cell lines. The gene discussed is TRPV3; the disease is lung carcinoma.